WHO: Global Alert and Response (GAR) – Disease Outbreak News: MERS-CoV; A(H7N9)

WHO: Global Alert and Response (GAR) – Disease Outbreak News
http://www.who.int/csr/don/2013_03_12/en/index.html
Middle East respiratory syndrome coronavirus (MERS-CoV) – update 5 July 2013
Excerpt
The Ministry of Health (MoH) in Saudi Arabia has announced two additional laboratory-confirmed cases and two deaths in previously confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in Saudi Arabia.

The new cases are a 69 year-old male and a 66 year-old male from Riyadh. Both were admitted to hospital on the 28 June 2013 and are currently in critical condition in an intensive care unit.

In addition, the two deaths in previously confirmed cases are a 63 year-old female from Riyadh and a 75 year-old male from Al Ahsa.

Globally, from September 2012 to date, WHO has been informed of a total of 79 laboratory-confirmed cases of infection with MERS-CoV, including 42 deaths.

Based on the current situation and available information, WHO encourages all Member States to continue their surveillance for severe acute respiratory infections (SARI) and to carefully review any unusual patterns…
.

Human infection with avian influenza A(H7N9) virus – update 4 July 2013
Excerpt
The National Health and Family Planning Commission, China notified WHO of an additional retrospectively detected laboratory-confirmed case of human infection with avian influenza A(H7N9) virus.

The patient is a 15-year-old boy reported from Jiangsu who became ill on 25 April 2013 and hospitalized on 26 April 2013. He recovered and was discharged on 2 May 2013. The results of molecular diagnostics were positive for H3N2 seasonal influenza virus and H7N9 avian influenza virus. On 1 July, Jiangsu Provincial Health Department consulted national and provincial experts for diagnosis.

To date, WHO has been informed of a total of 133 laboratory-confirmed cases, including 43 deaths.

Authorities in affected locations continue to maintain surveillance, epidemiological investigations, close contact tracing, clinical management, laboratory testing and sharing of samples as well as prevention and control measures.

So far, there is no evidence of sustained human-to-human transmission…